» Articles » PMID: 33362776

Effects of Gluten Challenge on PBMC Gene Expression Profiles in Diet Treated Celiac Disease

Overview
Journal Front Immunol
Date 2020 Dec 28
PMID 33362776
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The pathological mechanisms that lead to the onset and reactivation of celiac disease (CD) remain largely unknown. While gluten free diet (GFD) improves the intestinal damage and associated clinical symptoms in majority of cases, it falls short of providing full recovery. Additionally, late or misdiagnosis is also common as CD presents with a wide range of symptoms. Clear understanding of CD pathogenesis is thus critical to address both diagnostic and treatment concerns. We aimed to study the molecular impact of short gluten exposure in GFD treated CD patients, as well as identify biological pathways that remain altered constitutively in CD regardless of treatment. Using RNAseq profiling of PBMC samples collected from treated CD patients and gluten challenged patient and healthy controls, we explored the peripheral transcriptome in CD patients following a short gluten exposure. Short gluten exposure of just three days was enough to alter the genome-wide PBMC transcriptome of patients. Pathway analysis revealed gluten-induced upregulation of mainly immune response related pathways, both innate and adaptive, in CD patients. We evaluated the perturbation of biological pathways in sample-specific manner. Compared to gluten exposed healthy controls, pathways related to tight junction, olfactory transduction, metabolism of unsaturated fatty acids (such as arachidonic acid), metabolism of amino acids (such as cysteine and glutamate), and microbial infection were constitutively altered in CD patients regardless of treatment, while GFD treatment appears to mostly normalize immune response pathways to "healthy" state. Upstream regulator prediction analysis using differentially expressed genes identified constitutively activated regulators relatively proximal to previously reported CD associated loci, particularly SMARCA4 on 19p13.2 and CSF2 on 5q31. We also found constitutively upregulated genes in CD that are in CD associated genetic loci such as MEF2BNB-MEF2B (BORCS8-MEF2B) on 19p13.11 and CSTB on 21q22.3. RNAseq revealed strong effects of short oral gluten challenge on whole PBMC fraction and constitutively altered pathways in CD PBMC suggesting important factors other than gluten in CD pathogenesis.

Citing Articles

Exploratory Analysis of Selected Components of the mTOR Pathway Reveals Potentially Crucial Associations with Childhood Malnutrition.

Palit P, Gazi M, Das S, Hasan M, Noor Z, Ferdous J Nutrients. 2022; 14(8).

PMID: 35458174 PMC: 9031007. DOI: 10.3390/nu14081612.


Expression of Selected Genes and Circulating microRNAs in Patients with Celiac Disease.

Domsa E, Berindan-Neagoe I, Budisan L, Braicu C, Para I, Tantau A Medicina (Kaunas). 2022; 58(2).

PMID: 35208504 PMC: 8878253. DOI: 10.3390/medicina58020180.

References
1.
Leonard M, Bai Y, Serena G, Nickerson K, Camhi S, Sturgeon C . RNA sequencing of intestinal mucosa reveals novel pathways functionally linked to celiac disease pathogenesis. PLoS One. 2019; 14(4):e0215132. PMC: 6472737. DOI: 10.1371/journal.pone.0215132. View

2.
Torinsson Naluai A, Saadat Vafa L, Gudjonsdottir A, Arnell H, Browaldh L, Nilsson S . Altered peripheral amino acid profile indicate a systemic impact of active celiac disease and a possible role of amino acids in disease pathogenesis. PLoS One. 2018; 13(3):e0193764. PMC: 5851604. DOI: 10.1371/journal.pone.0193764. View

3.
Goel G, Tye-Din J, Qiao S, Russell A, Mayassi T, Ciszewski C . Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease. Sci Adv. 2019; 5(8):eaaw7756. PMC: 6685723. DOI: 10.1126/sciadv.aaw7756. View

4.
Tempera I, De Leo A, Kossenkov A, Cesaroni M, Song H, Dawany N . Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. J Virol. 2015; 90(1):345-55. PMC: 4702570. DOI: 10.1128/JVI.02318-15. View

5.
Drier Y, Sheffer M, Domany E . Pathway-based personalized analysis of cancer. Proc Natl Acad Sci U S A. 2013; 110(16):6388-93. PMC: 3631698. DOI: 10.1073/pnas.1219651110. View